Ovarian Overstimulation and Cystic Formation in Premenopausal Tamoxifen Exposure: Comparison between Tamoxifen-Treated and Nontreated Breast Cancer Patients

By Cohen I.   Figer A.   Tepper R.   Shapira J.   Altaras M.M.   Yigael D.   Beyth Y.  

Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. : 202-207

Elsevier

Access to resources Recommend Favorite

Comparison of Endometrial Changes among Symptomatic Tamoxifen-Treated and Nontreated Premenopausal and Postmenopausal Breast Cancer Patients

By Cheng W.-F.   Lin H.-H.   Torng P.-L.   Huang S.-C.  

Gynecologic Oncology, Vol. 66, Iss. 2, 1997-08 ,pp. : 233-237

Elsevier

Access to resources Recommend Favorite

Preliminary Assessment of Cognitive Function in Breast Cancer Patients Treated with Tamoxifen

By Paganini-Hill A.   Clark L.J.  

Breast Cancer Research and Treatment, Vol. 64, Iss. 2, 2000-11 ,pp. : 165-176

Springer Publishing Company

Access to resources Recommend Favorite

Malignant Endometrial Polyps in Postmenopausal Breast Cancer Tamoxifen-Treated Patients

By Cohen I.   Bernheim J.   Azaria R.   Tepper R.   Sharony R.   Beyth Y.  

Gynecologic Oncology, Vol. 75, Iss. 1, 1999-10 ,pp. : 136-141

Elsevier

Access to resources Recommend Favorite

Endometrial Histopathology in 700 Patients Treated with Tamoxifen for Breast Cancer

By Deligdisch L.   Kalir T.   Cohen C.J.   de Latour M.   Le Bouedec G.   Penault-Llorca F.  

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 181-186

Elsevier

Access to resources Recommend Favorite